SBFM
Sunshine Biopharma·NASDAQ
--
--(--)
--
--(--)
5.33 / 10
Netural
Money flow analysis indicates robust fund inflow activity with a 7.18/10 score; small-cap flows are positive while larger blocks remain negative. Analyst coverage is limited to one institution but is unanimously bullish with a 100% historical win rate, adding a constructive note to the outlook.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-10-08
InstitutionAegis Capital
Times predicted1
Historical Win Rate100.0%
Is money flowing into or out of SBFM?
- SBFM holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.33/10 (Netural).
